The National Institute on Deafness and Other Communication Disorders (NIDCD) is accepting cooperative agreement applications for investigator initiated clinical trials in communication disorders with the goal of advancing interventions into standard clinical care through well-designed and well-implemented clinical trials. It specifically seeks to support a clinical trial that meets any of the following criteria: requires FDA oversight, is intended to formally establish efficacy, or has potentially higher risks to participants. Amount: $500,000. Deadline: 1/27/25 (LOI).
- Home
- Uncategorized
- NIDCD’s Cooperative Agreement for Clinical Trials in Communication Disorders, LOI due Jan. 27, 2025